Coal tar
This article was originally published in The Rose Sheet
Executive Summary
Animal data on carcinogenic risk of dandruff shampoo ingredient are insufficient to support a change in OTC monograph status or new labeling warnings, J&J subsidiary Neutrogena asserts in Oct. 24 comments to FDA. Stressing its opposition to restrictions on coal tar-containing OTCs requested by Occupational Knowledge International in a March petition, the T/Gel marketer also notes the research cited by the petitioners examined "coal tar oil, not coal tar" (1"The Rose Sheet" April 3, In Brief). Neutrogena is one of several defendants in the ongoing Prop 65 lawsuit over coal tar in OTCs brought by Occupational Knowledge International and California Attorney General Bill Lockyer